mazdaki
Long

CERS- There is substantial Market for PI Platelets

NASDAQ:CERS   CERUS CORP
17 2 0
with serial FDA approvals, there will be institutional buyers accumulating this stock. Started an initial position and will add on weakness.
adding on at this point the move down so far should weed out weak hands. Cupand handle formation.
Reply
will reduce position in the 15-20 range.
Reply
United States
United Kingdom
India
Deutschland
España
France
Việt Nam
Italia
Polska
Brasil
Россия
Türkiye
Indonesia
Malaysia
日本
한국
简体
繁體
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing Support Priority Support Report Issue Ideas Published Followers Following Private Messages Chat Sign Out